Niagen Bioscience (NAGE) EBT Margin (2010 - 2026)
Niagen Bioscience (NAGE) reported EBT Margin of 21.4% for Q1 2026, up 424.0% year-over-year from 4.08% in Q1 2025, and up 63.68% quarter-over-quarter from 13.07% in Q4 2025.
Niagen Bioscience (NAGE) EBT Margin (2010 - 2026) Analysis & Trends
Niagen Bioscience (NAGE) has 17 years of EBT Margin data on file, last reported at 21.4% in Q1 2026.
- EBT Margin for Q1 2026 came in at 21.4%, up 424.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 15.1% (up 159.0% YoY), and the FY2025 annual result was 14.06%, up 517.0% from the prior year.
- EBT Margin grew to 21.4% in Q1 2026 per NAGE's latest filing, from 13.07% in the prior quarter.
- Over five years, EBT Margin peaked at 25.7% in Q4 2024 and troughed at 44.85% in Q1 2022.
- A 5-year average of 1.37% and a median of 0.07% in 2024 frame the typical range for EBT Margin.
- The sharpest annual moves came in 2023 and 2025: EBT Margin soared 3612 bps in 2023, then tumbled 1262 bps in 2025.
- A 5-year view of EBT Margin shows it stood at 6.88% in 2022, then jumped by 108 bps to 0.54% in 2023, then surged by 4678 bps to 25.7% in 2024, then plunged by 49 bps to 13.07% in 2025, then surged by 64 bps to 21.4% in 2026.
- Business Quant data shows NAGE's EBT Margin at 21.4% in Q1 2026, 13.07% in Q4 2025, and 14.12% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 6.40% |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 41.95% |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Niagen Bioscience | 280.11 Mn | 213.56 Mn | 19.98 Mn | 21.40% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21.40% |
| Dec 31, 2025 | 13.07% |
| Sep 30, 2025 | 14.12% |
| Jun 30, 2025 | 12.01% |
| Mar 31, 2025 | 17.16% |
| Dec 31, 2024 | 25.70% |
| Sep 30, 2024 | 7.34% |
| Jun 30, 2024 | -0.07% |
| Mar 31, 2024 | -2.22% |
| Dec 31, 2023 | 0.54% |
| Sep 30, 2023 | -4.92% |
| Jun 30, 2023 | -10.78% |
| Mar 31, 2023 | -8.72% |
| Dec 31, 2022 | -6.88% |
| Sep 30, 2022 | -17.99% |
| Jun 30, 2022 | -38.23% |
| Mar 31, 2022 | -44.85% |
| Dec 31, 2021 | -29.98% |
| Sep 30, 2021 | -51.17% |
| Jun 30, 2021 | -31.45% |